Healthy adults
Conditions
Interventions
Test with fat load
Sponsors
Hokkaido Information University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.subjects whose TG is 50 mg / dl or more and less than 150 mg / dl, or 150 mg / dl or more.
Exclusion criteria
Exclusion criteria: 1.Subjects using anticoagulants (such as warfarin), antiplatelet drugs (aspirin, clopidogrel, ticlopidine, cilostazol etc.), coagulation accelerators (calcium solution, thrombin, vitamin K, etc.). 2.Subjects with blood clotting disease (hemophilia, platelet asthenia, warfarin administration, liver failure, etc). 3.Subjects who may have allergic symptoms in dairy products. 4.Subjects who received physician treatment, medication, and life guiduance for obesity, dyslipidemia, diabetes. 5.Subjects suffering from severe cerebrovascular disease, heart disease, liver disease, kidney disease, gastrointestinal disease, endocrine metabolic disease, infection requiring notification. 6.Subjects using pacemakers and defibrillators. 7.Subjects who have injuries, atopic skin diseases, contact dermatitis, rashes, etc. on the skin of the upper arm. 8.Subjects with major surgical history relevant to the digestive system. 9.Subjects with unusually high, low blood pressure, abnormal hematological data, severe anemia. 10.Pre- or post-menopausal women complaining of obvious physical changes. 11.Excess smokers and regulars alcohol addicts or subjects with eating disordered lifestyle. 12.Subjects who donated a predetermined amount of blood in a given period. 13.Pregnant or lactating women or women who expect to be pregnant during this study. 14.Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 15.Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood triglyceride level by noninvasive measuring instrument Blood triglyceride concentration by free glycerol elimination method | — |
Secondary
| Measure | Time frame |
|---|---|
| Height, body weight, BMI, body fat percentage, blood pressure, pulse rate, blood flow, skin surface temperature,Ht,TC, LDL-C, HDL-C,casual blood glucose level,Apolipoprotein,Lipoprotein fraction,AST, ALT, r-GTP, ALP, LDH,BUN, CRE, UA, Alb, TP, T-Bil, CPK | — |
Countries
Japan
Contacts
Public ContactDir. Prof. Jun NISHIHIRA, M.D., Ph.D.
Hokkaido Information University Health Information Science Center
Outcome results
None listed